CombiGene and Panion attend BIO 2016 in SanFrancisco

The world’s largest biotech convention takes place June 6-9 in San Francisco. It is BIO International Convention (BIO) that returns to the birthplace of biotech: San Francisco and the Bay Area. CombiGene AB is represented by CEO Bengt Westrin, and Panion Animal Health AB is also present through Carlos Velez.

Over 15 000 industry leaders, business developers, scientists and other professionals will come to BIO2016 for networking or for participating in some of the numerous One-on-One partnering meetings which often can be the starting point of a longer collaboration. Almost 2 000 companies will exhibit and there is a number of side conferences, company presentations, courses etc. Most of the large pharma and biotech companies will attend the convention and so will a large number of small development companies, contract research organization, universities and other public organization from all over the world.

CombiGene’s main objective is to meet medium sized and large pharma companies, but also to meet companies with capacity for large scale GMP manufacturing of AAV vectors as well as some other highly specialized service providers. Several One-on-One meetings have already been agreed.

The newly started Panion Animal Health AB is not attending under its own brand, but Panion’s soon-to-be Director of Business Development Carlos Velez (Lacerta Bio) will be present and has the aim to meet animal health companies attending BIO2016.

Read more about BIO2016 at http://convention.bio.org/2016/ .

For further information:

CombiGene AB (publ)

Bengt Westrin, CEO

Tel: +46 70 265 48 62

email: bengt.westrin@combigene.com

About CombiGene AB

By combining modern neuroscience with recent advances in gene delivery, CombiGene has developed a method shown to suppress epileptic seizures in preclinical studies. Current focus is on continuing to develop this method into an effective and safe therapy for epilepsy patients, but the method may also have development potential as a means of treating other neurological disorders. Founded on the basis of scientific discoveries made at Lund University and the University of Copenhagen, CombiGene has offices at Medicon Village in Lund, Sweden. The company is public and listed on the Swedish marketplace AktieTorget. www.combigene.com .

About Panion Animal Health AB

Panion Animal Health AB is a wholly owned subsidiary of CombiGene AB and was founded in July 2015 with the purpose to develop and commercialize the animal health application of CombiGene’s technology. At CombiGene AB’s Annual Shareholders’ Meeting on April 4th 2016 it was decided to distribute Panion to CombiGene’s shareholders. The record date for the distribution will be July 8th 2016, after which the aim is to list the company at a feasible marketplace. A website will be launched at www.panion-animalhealth.com.

MORE FROM THE COMPANY is a newsletter from CombiGene which contains general news and information that is judged not to have a significant effect on the share price. Other issues of MORE FROM THE COMPANY and PRESS RELEASES are available at www.combigene.com.

Subscribe

Documents & Links